Department of Medicine, Children's Hospital Boston, Boston, Massachusetts, USA.
Otolaryngol Head Neck Surg. 2011 Jun;144(6):838-43. doi: 10.1177/0194599811399538. Epub 2011 Mar 31.
To use meta-analytic techniques to examine the effect of dexamethasone on the risk of postoperative bleeding following tonsillectomy.
PubMed and Embase databases accessed on April 23, 2009, and April 28, 2009.
Using principles of meta-analysis, inclusion and exclusion criteria were developed to identify all randomized controlled trials of patients undergoing tonsillectomy in which perioperative intravenous dexamethasone was administered in at least 1 treatment arm and bleeding complications were reported. Electronic databases were searched to identify candidate articles. Two authors independently abstracted data from each article. Discrepancies were resolved by consensus. A fixed-effects model was used to pool relative risks among studies using the Mantel-Haenszel method. Studies were assessed for publication bias using a funnel plot of studies' effect size vs standard error of the effect size as well as Begg test and Egger test. A P value <.05 was considered significant.
The primary search identified 85 potential studies. Fourteen met inclusion criteria and were selected for meta-analysis. No significant heterogeneity was found among studies (I(2)< 0.1%; 95% confidence interval [CI], 0%-55%; P = .68). The pooled relative risk (RR) of postoperative bleeding did not differ significantly between patients receiving dexamethasone and controls (RR, 1.02; 95% CI, 0.65-1.61; P = .92). When studies were stratified by age, primary vs secondary hemorrhage, and follow-up duration, no further significant differences in bleeding rate were identified. No evidence of publication bias was found using Begg (P = .70) or Egger (P = .73) tests.
The results of this meta-analysis indicate that perioperative dexamethasone does not confer an increased risk of postoperative bleeding in patients undergoing tonsillectomy.
使用荟萃分析技术,研究地塞米松对扁桃体切除术后出血风险的影响。
2009 年 4 月 23 日和 4 月 28 日检索 PubMed 和 Embase 数据库。
采用荟萃分析的原理,制定纳入和排除标准,以确定所有接受扁桃体切除术的患者的随机对照试验,这些患者在至少一个治疗组中接受围手术期静脉内地塞米松治疗,并报告出血并发症。检索电子数据库以确定候选文章。两位作者独立地从每篇文章中提取数据。通过共识解决分歧。使用 Mantel-Haenszel 方法,使用固定效应模型对研究中的相对风险进行汇总。使用研究效应大小与效应大小标准误的漏斗图以及 Begg 检验和 Egger 检验评估研究的发表偏倚。P 值<0.05 被认为有统计学意义。
主要搜索确定了 85 项潜在的研究。14 项符合纳入标准,并被选入荟萃分析。研究之间没有发现显著的异质性(I(2)<0.1%;95%置信区间 [CI],0%-55%;P=0.68)。接受地塞米松治疗的患者与对照组相比,术后出血的相对风险(RR)没有显著差异(RR,1.02;95%CI,0.65-1.61;P=0.92)。当根据年龄、原发性与继发性出血和随访时间对研究进行分层时,出血率没有进一步显著差异。Begg 检验(P=0.70)和 Egger 检验(P=0.73)均未发现发表偏倚的证据。
这项荟萃分析的结果表明,围手术期地塞米松不会增加扁桃体切除术后出血的风险。